Lisa Earnhardt

President and Chief Executive Officer
Intersect ENT

Prior to joining Intersect ENT, Ms. Earnhardt was the President of Boston Scientific’s Cardiac Surgery division, where she played an instrumental role in the sale of that business to the Getinge Group in January 2008 (now known as Maquet Cardiovascular). Previously, Ms. Earnhardt held a variety of sales and marketing positions of increasing responsibility at Guidant. She has extensive experience with global product launches and driving adoption of new technologies including implantable cardiac defibrillators, endoscopic vessel harvesting, surgical ablation and beating heart bypass surgery. Ms. Earnhardt began her career at APM Incorporated (now CSC Healthcare) in San Francisco where she provided management consulting services to healthcare provider organizations. Ms. Earnhardt holds an MBA from Northwestern’s Kellogg School of Management and a BS in Industrial Engineering from Stanford University. She serves on the boards of Intersect ENT, Kensey Nash Corporation (Nasdaq: KNSY), and the Kellogg Alumni Council and is a member of the Young Presidents’ Organization (YPO).